These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 17925622

  • 1. Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study.
    May M, Lawlor DA, Patel R, Rumley A, Lowe G, Ebrahim S.
    Eur J Cardiovasc Prev Rehabil; 2007 Oct; 14(5):638-45. PubMed ID: 17925622
    [Abstract] [Full Text] [Related]

  • 2. Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men.
    Wannamethee SG, Whincup PH, Lennon L, Rumley A, Lowe GD.
    Stroke; 2012 May; 43(5):1206-11. PubMed ID: 22382157
    [Abstract] [Full Text] [Related]

  • 3. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
    Yarnell J, McCrum E, Rumley A, Patterson C, Salomaa V, Lowe G, Evans A.
    Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045
    [Abstract] [Full Text] [Related]

  • 4. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
    Pradhan AD, LaCroix AZ, Langer RD, Trevisan M, Lewis CE, Hsia JA, Oberman A, Kotchen JM, Ridker PM.
    Circulation; 2004 Jul 20; 110(3):292-300. PubMed ID: 15238458
    [Abstract] [Full Text] [Related]

  • 5. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population.
    Rudnicka AR, Rumley A, Lowe GD, Strachan DP.
    Circulation; 2007 Feb 27; 115(8):996-1003. PubMed ID: 17296859
    [Abstract] [Full Text] [Related]

  • 6. Prospective study of seasonal patterns in hemostatic factors in older men and their relation to excess winter coronary heart disease deaths.
    Ghebre MA, Wannamethee SG, Rumley A, Whincup PH, Lowe GD, Morris RW.
    J Thromb Haemost; 2012 Mar 27; 10(3):352-8. PubMed ID: 22235876
    [Abstract] [Full Text] [Related]

  • 7. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study.
    Lowe GD, Yarnell JW, Sweetnam PM, Rumley A, Thomas HF, Elwood PC.
    Thromb Haemost; 1998 Jan 27; 79(1):129-33. PubMed ID: 9459337
    [Abstract] [Full Text] [Related]

  • 8. Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study.
    Langer RD, Pradhan AD, Lewis CE, Manson JE, Rossouw JE, Hendrix SL, LaCroix AZ, Ridker PM.
    Thromb Haemost; 2005 Jun 27; 93(6):1108-16. PubMed ID: 15968396
    [Abstract] [Full Text] [Related]

  • 9. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.
    Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G.
    Circulation; 2005 Nov 15; 112(20):3080-7. PubMed ID: 16286603
    [Abstract] [Full Text] [Related]

  • 10. Lifestyle and hemostatic risk factors for ischemic heart disease : the Caerphilly Study.
    Yarnell JW, Sweetnam PM, Rumley A, Lowe GD.
    Arterioscler Thromb Vasc Biol; 2000 Jan 15; 20(1):271-9. PubMed ID: 10634829
    [Abstract] [Full Text] [Related]

  • 11. The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.
    Rautio A, Boman K, Gerstein HC, Hernestål-Boman J, Lee SF, Olofsson M, Mellbin LG.
    Diab Vasc Dis Res; 2017 Jul 15; 14(4):345-352. PubMed ID: 28403644
    [Abstract] [Full Text] [Related]

  • 12. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women.
    Lawlor DA, Davey Smith G, Ebrahim S, Thompson C, Sattar N.
    J Clin Endocrinol Metab; 2005 Oct 15; 90(10):5677-83. PubMed ID: 16076942
    [Abstract] [Full Text] [Related]

  • 13. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men.
    Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH.
    Atherosclerosis; 2005 Jul 15; 181(1):101-8. PubMed ID: 15939060
    [Abstract] [Full Text] [Related]

  • 14. Altered endothelial function following the Fontan procedure.
    Binotto MA, Maeda NY, Lopes AA.
    Cardiol Young; 2008 Feb 15; 18(1):70-4. PubMed ID: 18093358
    [Abstract] [Full Text] [Related]

  • 15. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
    Wannamethee SG, Sattar N, Rumley A, Whincup PH, Lennon L, Lowe GD.
    Diabetes Care; 2008 May 15; 31(5):995-1000. PubMed ID: 18235054
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease.
    Woodward M, Rumley A, Welsh P, MacMahon S, Lowe G.
    J Thromb Haemost; 2007 Sep 15; 5(9):1795-800. PubMed ID: 17723116
    [Abstract] [Full Text] [Related]

  • 17. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease.
    Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumley A, Wallace AM, Sattar N.
    Atherosclerosis; 2007 Apr 15; 191(2):418-26. PubMed ID: 16712853
    [Abstract] [Full Text] [Related]

  • 18. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.
    Warshofsky MK, Wasserman HS, Wang W, Teng P, Sciacca R, Apfelbaum M, Schwartz A, Michler RE, Mancini DM, Cannon PJ, Rabbani LE.
    Am J Cardiol; 1997 Jul 15; 80(2):145-9. PubMed ID: 9230149
    [Abstract] [Full Text] [Related]

  • 19. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
    Smith FB, Lee AJ, Hau CM, Rumley A, Lowe GD, Fowkes FG.
    Blood Coagul Fibrinolysis; 2000 Jan 15; 11(1):43-50. PubMed ID: 10691098
    [Abstract] [Full Text] [Related]

  • 20. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.
    Schved JF, Gris JC, Arnaud A, Martinez P, Sanchez N, Wautier JL, Sarlat C.
    J Lab Clin Med; 1992 Sep 15; 120(3):411-9. PubMed ID: 1517688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.